Cosentyx snrdy 300MG dose-2PENML
Ended Awarded
- Contract number
- SPE2DR26F8YFS
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,363
Award facts
- Contract value 100% obligated
- $12,363.06 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,363.06 to AmerisourceBergen Drug Corp for the supply of Cosentyx (secukinumab) 300mg dose in 2 pen/mL formulation. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of October 22, 2025. The award was made on October 21, 2025, and the pharmaceutical product will be delivered to AmerisourceBergen's place of performance in Conshohocken, Pennsylvania. Cosentyx is a biologic immunosuppressant used to treat autoimmune conditions, and this order represents a routine procurement through DLA's medical supply chain supporting military and federal healthcare systems.
This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and active through December 2026. This prime vendor contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. The company's competitive award of this delivery order reflects its established capability to meet federal pharmaceutical procurement requirements through open competition, positioning it as a key supplier within DLA's pharmaceutical and medical supply logistics framework.
Quick answers
Who was awarded contract SPE2DR26F8YFS?
SPE2DR26F8YFS was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 21, 2025.
How much is contract SPE2DR26F8YFS worth?
The government has obligated $12,363 on SPE2DR26F8YFS.
Is contract SPE2DR26F8YFS an order under another contract?
Yes. SPE2DR26F8YFS is a delivery order under SPE2DR25D1017, an indefinite delivery contract.
Was contract SPE2DR26F8YFS competed?
The extent of competition for SPE2DR26F8YFS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award